title: What to measure in autism drug trials.
authors.forename: B
authors.initials: B
authors.lastname: Roseman
authors.forename: E
authors.initials: E
authors.lastname: Schneider
authors.forename: D
authors.initials: D
authors.lastname: Crimmins
authors.forename: H
authors.initials: H
authors.lastname: Bostwick
authors.forename: P
authors.initials: P
authors.lastname: Visintainer
authors.forename: P A
authors.initials: PA
authors.lastname: Jaskow
authors.forename: P
authors.initials: P
authors.lastname: Accardo
mesh_terms: D001321:Autistic Disorder / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012633:Secretin / Q000008:administration & dosage / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
chemical_list: D005765:Gastrointestinal Agents; D012633:Secretin